Effects of Onodera′s prognostic nutritional index on the prognosis of locally advanced oropharyngeal squamous cell carcinoma after induction chemotherapy followed by sequential chemoradiotherapy / 中华放射医学与防护杂志

Objective:To explore the effects of Onodera′s prognostic nutritional index (PNI) on the prognosis of locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC) after induction chemotherapy followed by sequential chemoradiotherapy.Methods:A retrospective analysis was conducted on the clinical data of 52 LA-OPSCC patients receiving induction chemotherapy followed by sequential chemoradiotherapy in The Affiliated Cancer Hospital of Guizhou Medical University during 2014-2018. The PNI values of all the patients at different treatment phases were statistically analyzed, and the ROC curve was employed to determine the optimal critical value of PNI. The patients in this study were divided into a well-nourished group ( n = 27) and a poorly-nourished group ( n = 25). The Kaplan-Meier method was used for survival analysis. The Cox proportional hazards model was utilized to analyze the relationships between different nutritional status and prognosis. Clinical features and adverse reactions were compared between the two groups. Results:The PNI values decreased significantly after radiotherapy, with an optimal critical value of 42.4. The 5-year overall survival (OS) and progression-free survival (PFS) of the well-nourished group (PNI ≥ 42.4) were 62.6% and 60.9%, respectively, which were significantly higher than those (30.1% and 29.7%) of the poorly-nourished group (PNI < 42.4, χ2 = 11.12, 5.74, P < 0.05). The multivariate analysis showed that PNI was an independent prognostic factor for the OS after radiotherapy ( HR = 2.752, 95% CI: 1.095-6.917, P = 0.031). The LA-OPSCC patients aged over 60 years or those who did not respond to induction chemotherapy accounted for a higher proportion of malnutrition after chemoradiotherapy ( χ2 = 4.89, 5.05, P < 0.05). Conclusions:PNI after radiotherapy can be used as a prognostic factor in the evaluation of LA-OPSCC patients receiving induction chemotherapy followed by sequential chemoradiotherapy. The LA-OPSCC patients aged over 60 years or those who do not respond to induction chemotherapy should receive more nutritional support during the chemoradiotherapy.

The clinical value of oral robotic surgery in the treatment of oropharyngeal squamous cell carcinoma / 中华肿瘤杂志

Objective: To explore the therapeutic effects of transoral robotic surgery (TORS) and traditional surgical modes in oropharyngeal squamous cell carcinoma (OPSCC). Methods: The clinicopathological data of patients with oropharyngeal squamous cell carcinoma treated at Sun Yat-sen University Cancer Center from 2010 to 2018 were retrospectively analyzed. 135 cases were treated with traditional surgery (non-TORS group), while 52 cases were treated with TORS (TORS group). The prognosis of the two groups of patients were analyzed by Kaplan-Meier method and Log rank test, the influencing factors were analyzed by Cox regression model. Results: The 2-year overall survival (OS, 94.2%) and 2-year progression-free survival (PFS, 93.8%) of patients in the TORS group were better than those in the non-TORS group (71.4% and 71.4%, respectively, P<0.05). The 2-year OS (93.3%) and 2-year PFS (92.8%) of TORS group patients in T1-2 stage were better than those of non-TORS group (73.1% and 72.8%, respectively, P<0.05). The 2-year OS (95.8%) and 2-year PFS (95.2%) of patients with stage Ⅰ to Ⅱ in the TORS group were not significantly different from those in the non-TORS group (84.1% and 83.9%, respectively, P>0.05). The 2-year OS (92.9%) and 2-year PFS rate (92.7%) of patients with stage Ⅲ to Ⅳ in the TORS group were better than those in the non-TORS group (64.7% and 63.9%, respectively, P<0.05). The 2-year OS (94.4%) of HPV-positive patients in the TORS group was not significantly different from that in the non-TORS group (83.3%, P=0.222). The 2-year OS of HPV-negative patients in the TORS group (94.1%) was significantly different from that in the non-TORS group (43.7%, P<0.001). HPV status was an independent prognostic factor (P=0.008). Conclusions: TORS has a better prognosis in the treatment of oropharyngeal squamous cell carcinoma compared with the traditional treatment methods. The patients with T1-T2 can achieve better survival benefits after TORS treatment. The HPV-positive OPSCC patients has a better prognosis than that of HPV-negative OPSCC patients, and regardless of HPV status, OPSCC patients in the TORS group could obtain a better survival prognosis.

Detection of human papillomavirus in oropharyngeal squamous cell carcinoma / 浙江大学学报（英文版）（B辑：生物医学和生物技术）

Worldwide there has been a significant increase in the incidence of oropharyngeal squamous cell carcinoma (OPSCC) etiologically attributed to oncogenic human papillomavirus (HPV). Reliable and accurate identification and detection tools are important as the incidence of HPV-related cancer is on the rise. Several HPV detection methods for OPSCC have been developed and each has its own advantages and disadvantages in regard to sensitivity, specificity, and technical difficulty. This review summarizes our current knowledge of molecular methods for detecting HPV in OPSCC, including HPV DNA/RNA polymerase chain reaction (PCR), loop-mediated isothermal amplification (LAMP), p16 immunohistochemistry (IHC), and DNA/RNA in situ hybridization (ISH) assays. This summary may facilitate the selection of a suitable method for detecting HPV infection, and therefore may help in the early diagnosis of HPV-related carcinoma to reduce its mortality, incidence, and morbidity.

Detection of human papillomavirus in oropharyngeal squamous cell carcinoma / 浙江大学学报（英文版）（B辑：生物医学和生物技术）

Worldwide there has been a significant increase in the incidence of oropharyngeal squamous cell carcinoma (OPSCC) etiologically attributed to oncogenic human papillomavirus (HPV). Reliable and accurate identification and detection tools are important as the incidence of HPV-related cancer is on the rise. Several HPV detection methods for OPSCC have been developed and each has its own advantages and disadvantages in regard to sensitivity, specificity, and technical difficulty. This review summarizes our current knowledge of molecular methods for detecting HPV in OPSCC, including HPV DNA/RNA polymerase chain reaction (PCR), loop-mediated isothermal amplification (LAMP), p16 immunohistochemistry (IHC), and DNA/RNA in situ hybridization (ISH) assays. This summary may facilitate the selection of a suitable method for detecting HPV infection, and therefore may help in the early diagnosis of HPV-related carcinoma to reduce its mortality, incidence, and morbidity.

Oropharyngeal squamous cell carcinoma: human papilloma virus coinfection with streptococcus anginosus

Abstract Introduction: Human papilloma virus (HPV) and oral bacteria capable of acetaldehyde production from ethanol, such as Streptococcus anginosus, Prevotella melaninogenica, and Fusobacterium naviforme are among oropharyngeal squamous cell carcinoma (OSCC) infectious risk factors. Objective: Determine associations with HPV and S. anginosus, P. melaninogenica, and F. naviforme in patients with and without OSCC. Methods: Presence of HPV and HPV-16 was determined in 26 patients with OSCC and 26 without OSCC by conventional PCR and simultaneous presence of S. anginosus, P. melaninogenica, and F. naviforme quantification through q-PCR. Statistical analysis was carried out using Pearson's X² and Student's-t test. Results: Patients with OSCC had HPV and HPV-16 frequencies of 84% and 61.5%, respectively, in contrast for patients without OSCC frequencies were 34.6 and 30.7%. P. melaninogenica, and F. naviforme microorganisms were not present in any participant in this study. S. anginosus frequency in patients with OSC was 38.4% and in patients without OSCC was 30.7%. Patients with OSCC had S. anginosus + HPV co-infection at a 38.4% frequency and S. anginosus + HPV-16 at a 23.1% frequency. For individuals without OSCC S. anginosus + HPV co-infection was 3.8% and S. anginosus + HPV-16 3.8%. A greater frequency of S. anginosus + HPV co-infection and S. anginosus + HPV-16 was observed in patients with OSCC in comparison with individuals without OSCC, suggesting the importance of detecting HPV/HPV-16 and S. anginosus simultaneously in individuals at risk of developing OSCC

Resumo O vírus do papiloma humano (VPH) e bactérias orais capacidade de produção acetaldeído a partir do etanol, tais como Streptococcus anginosus, Prevotella melaninogenica e Fusobacterium naviforme, estão entre os fatores de risco infecciosos do carcinoma de células escamosas de orofaringe (CCEO). Determinar associações o VPH e S. anginosus, P. melaninogenica, e F. naviforme em pacientes com e sem o CCEO. A presença de VPH e VPH-16 foi determinada em 26 pacientes com CCEO e 26 sem CCEO por PCR convencional e presença simultânea de quantificação de S. anginosus, P. melaninogenica e F. naviforme por meio de q-PCR. Uma análise estatística foi realizada por meio do t-Student e χ² de Pearson. Os pacientes com CCEO apresentaram frequências de VPH e VPH-16 de 84% e 61,5%, respectivamente, em contraste, para os pacientes sem CCEO frequências de 34,6 e 30,7%. Os microorganismos P. melaninogenica e F. naviforme não estavam presentes em nenhum dos participantes deste estudo. A freqüência de S. anginosus em pacientes com CCEO foi de 38,4% e em pacientes sem CCEO foi de 30,7%. Os pacientes com CECO apresentaram coinfecção com S. anginosus + VPH em uma freqüência de 38,4% e S. anginosus + VPH-16 com freqüência de 23,1%. Para os indivíduos sem CCEO, co-infecção com S. anginosus + VPH foi de 3,8% e S. anginosus + VPH-16 foi de 3,8%. A Maior frequência de co-infecção com S. anginosus + VPH e S. anginosus + VPH-16 foi observada em pacientes com CCEO em comparação com indivíduos sem CCEO, sugerindo a importância da detecção de VPH / VPH-16 e S. anginosus simultaneamente em indivíduos em risco de desenvolver CCEO.

Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma

OBJECTIVE: To determine whether radiologic extranodal extension (ENE) appearing on pretreatment CT and MRI could predict the prognosis in patients with human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC). MATERIALS AND METHODS: The study population was obtained from a historical cohort diagnosed with HPV-related OPSCC. A total of 134 OPSCC patients who had a metastatic lymph node on pretreatment CT or MRI were included, and radiologic ENE was evaluated by two experienced head and neck radiologists. Kaplan-Meier and multivariate Cox regression analyses were performed to evaluate the impact of radiologic ENE on progression-free survival (PFS). The diagnostic performance of CT and MRI for the diagnosis of ENE was also evaluated in patients who underwent neck dissection. RESULTS: Seventy patients (52.2%) showed radiologic ENE-positive findings. Although patients showing radiologic ENE had a worse 3-year PFS (83.7% vs. 95.3%, p = 0.023), the association between radiologic ENE and PFS was not statistically significant on multivariate analysis (p = 0.141; hazard ratio, 2.68; 95% confidence interval, 0.72–9.97). CT or MRI had a sensitivity of 62%, specificity of 77.8%, and accuracy of 71.9% for predicting pathologic ENE. CONCLUSION: Radiologic ENE on CT or MRI did not predict poor PFS in patients with HPV-related OPSCC, although there was a trend towards worse PFS. Further studies are warranted to determine whether radiologic ENE is a useful imaging biomarker to risk-stratify patients with HPV-related OPSCC.

Virus papiloma humano en cáncer oral y orofaríngeo: revisión de la literatura / Human papilloma virus in oral and oropharyngeal cancer: review of the literature

Estudios recientes demuestran una realidad prácticamente ineludible que manifiesta que el Virus Papiloma Humano (VPH) puede estar asociado al desarrollo del Carcinoma de Células Escamosas en cavidad oral y orofarínge. Desde el descubrimiento en 1974 por parte de zur Hausen et al., quienes ayudaron a definir el mecanismo por medio del cual el VPH provoca la transformación del queratinocito normal a un estado maligno, han sido numerosos los estudios que han descrito la presencia del VPH en carcinomas de cabeza y cuello, específicamente en cavidad oral y orofarínge. La detección del virus en estos carcinomas podría tener implicaciones clínicas importantes en el pronóstico y tratamiento de estos tumores, con resultados más favorables para el paciente; así mismo, justificar planes de prevención orientados al diagnóstico temprano y a la protección específica contra el VPH. Actualmente están en desarrollo terapias experimentales mínimamente invasivas que potencian el sistema inmunitario para atacar estos tumores, sin embargo, aún no están aprobadas para su uso general. En Chile todavía no existen estudios que describan la situación actual del VPH con respecto al Carcinoma de Células Escamosas en cavidad oral y orofarínge que pudieran orientar al sistema de salud con respecto a la prevención y tratamiento de este tipo de cáncer. En esta revisión presentamos los principales aspectos que relacionan al virus con este tipo de carcinoma. Se revisaron artículos indexados en inglés (Pubmed, Scopus, Cochrane Library, Google Scholar) y español (SciELO, Google Scholar), con el objetivo de brindar al Odontólogo general y especialistas una información actualizada sobre este tema, tanto desde su epidemiología como desde los mecanismos de acción carcinogénica del virus, técnicas de diagnóstico avanzadas, además, formas de prevención y estado del arte en materia de tratamiento.

Recent studies indicate what has become a nearly inescapable reality in that Human Papilloma Virus can be associated to the development of Oral and Oropharyngeal Squamous Cell Carcinoma. Since the discovery of zur Hausen et al. that helped define the mechanism by which HPV causes normal keratinocyte transformation to a malignant state, there have been numerous studies that have described the presence of HPV in head and neck carcinomas, specifically in oral cavity and oropharynx. The detection of the virus in these carcinomas may have important clinical implications in the prognosis and treatment of these tumors with more favorable patient outcomes; likewise, justify prevention plans aimed at early diagnosis and specific protection against HPV. Currently minimally invasive experimental therapies that boost the immune system to attack these tumors are in development, however, they are not yet approved for general use. In Chile there are no studies that describe the current situation with regard to HPV Squamous Cell Carcinoma in oral cavity and oropharynx that may guide the health system regarding the prevention and treatment of this cancer. In this review we present the principal aspects that associate the virus with this type of oral and oropharyngeal carcinoma. We reviewed indexed articles in English (Pubmed, Scopus, Cochrane Library, Google Scholar) and Spanish (SciELO, Google Scholar), with the objective to provide Dental Surgeons and specialists the most updated information about this subject. The review was developed considering the epidemiology as well as the carcinogenic mechanisms of the virus, advanced diagnostic techniques, ways of prevention and state of the art in treatment matters.

Angiogenesis and p53 Mutation in Oral and Oropharyngeal Squamous Cell Carcinoma / 대한이비인후과학회지

BACKGROUND AND OBJECTIVES: It is well known that microvessel density (MVD) and p53 gene mutation are significantly correlated with tumor behaviors in some types of cancer: however, some studies have reported a lack of relationship among MVD, p53 gene mutation and tumor behavior in oral cancers. The objective of this study was to identify putative association between p53 gene mutation and microvessel density (MVD) and to evaluate the usefulness of this association in deciding the therapeutic plan. MATERIALS AND METHODS: In 25 tumor specimens of oral squarnous cell carcinoma, microvessel density (MVD) was analysed by immunohistorhemical staining with CD-31 monoclonal antibody, and p53 mutation was examined in exon 5 through 8 by PCR-SSCP and sequencing analysis. RESULTS: Seven of the 25 patients had mutation in exon 5 to 8 and all the mutations were missense mutation. The mean of MVD in the mutant group was 13.3+/-2.80 and that of MVD in the wild type group was 18.6+/-1.16. An inverse relationship was seen between MVD and p53 mutation (p=0.047). The p53 gene mutation was frequently found in exon 5. CONCLUSION: MVD and p53 gene mutation were not associated with respect to stage, cervical metastasis and recurrence of' the oral and oropharyngeal cancer. Angiogenesis of oral squamous cell carcinoma might not be regulated by p53, but might be regulated by other factors.

A Double Immunohistochemical Study on the Expression of Matrix Metalloproteinase-2 and Type IV Collagen in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx / 대한이비인후과학회지

BACKGROUND AND OBJECTIVES: Matrix metalloproteinase-2 (MMP-2) is produced by tumor cells that specifically cleaves type IV collagen, one of the major constituents of basement membrane. The MMP-2 and type IV collagen have been postulated to have an important role in the invasion and spread of malignant tumors. However, little has been reported about expression of MMP-2 and type IV collagen in primary tumors and metastatic lymph nodes of oral cavity and oropharynx simultaneously. So we investigated that MMP-2 and type IV collagen can be used as the prognostic indicators of metastasis in squamous cell carcinoma of oral cavity and oropharynx. MATERIALS AND METHODS: Double immunohistochemistry was used to detect MMP-2 and type IV collagen in 32 primary tumors (14 cases had metastatic nodes and 18 cases had no metastatic node) of surgically treated squamous cell carcinoma of the oral cavity and oropharynx. The findings were compared to clinical findings of each cases. RESULTS: The immunoreactivity of MMP-2 increased significantly as more destructive patterns of basement membrane components in primary tumor (p=0.019) than metastatic lymph nodes. The cases with cervical metastasis showed more destructive patterns than cases with absence of cervical metastasis in primary tumor (p=0.003), but expression of MMP-2 had no correlation with presence or absence of cervical metastasis. The cases with diffuse invasion showed more destructive pattern than cases with any other patterns in primary tumor. However, expression of MMP-2 had no correlation with invasion mode of primary tumor. In metastatic lymph node, neither of them had no correlation with invasion mode. No statistical correlations in expression of MMP-2 and type IV collagen were detected between primary tumor and metastatic lymph nodes. CONCLUSION: The expression patterns of MMP-2 and type IV collagen in oral cavity and oropharyngeal squamous cell carcinoma can be useful in predicting cervical metastasis.

Expression of p53 and Epidermal Growth Factor Receptor in the Oral and Oropharyngeal Squamous Cell Carcinomas / 대한이비인후과학회지

The prognostic significance of the squamous cell carcinomas of the oral and oropharynx have been evaluated to identify those features associated with aggressive biologic behavior according to the immunologic and histologic characteristics. For determining prognostic indicators, the authors performed immunohistochemical staining of p53 and epidermal growth factor receptor(EGFR) in 29 cases of squamous cell carcinomas of the oral and oropharynx. The expression rate of p53 was 51.7%, that of EGFR was 96.6%, and overexpression rate of EGFR was 41.4%, however there were no statistical significance between the reactivity of EGFR, p53 and clinicopathological features such as primary stage, nodal stage, clinical stage, death and histologic grade.